Antibacterial Therapy and Newer Agents , An Issue of Medical Clinics of North America

This issue of Medical Clinics of North America brings the physician up to date on the newest agents for antibacterial therapy. New drugs are covered, as well as new approaches. Topics include the newer fluoroquinolones; epidemiology, molecular mechanisms, and clinical management of pathogens resistant to antibacterial agents; current use for old antibacterial agents, including polymyxins, rifamycins, and aminoglycosides; topical antibacterial agents; newer beta-lactam antibiotics, including doripenem, ceftobiprole. ceftaroline, and cefepim; the use of antibacterial agents in renal failure; antibiotics for gram positive bacterial infections, including vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinolones, daptomycin, telavancin, and ceftaroline; as well as macrolides, ketolides, and glycylcyclines, including azithromycin, clarithromycin, telithromycin, and tigecycline.

Product details

• Authors: Donald Kaye, Keith Kaye, Keith S Kaye, Keith S. Kaye, Kaye Donald, Kaye Keith S.
• Publisher: Elsevier Health Science
• Languages: English
• Product format: Hardback
• Released: 01.07.2011
• EAN: 9781455722914
• ISBN: 978-1-4557-2291-4
• Dimensions: 152 mm x 228 mm x 229 mm
• Weight: 430 g
• Series: The Clinics: Internal Medicine; Medical Clinics of North Ameri
• Subjects: Natural sciences, medicine, IT, technology > Medicine > Clinical medicine; MEDICAL / Clinical Medicine, MEDICAL / Pharmacy, MEDICAL / Internal Medicine, MEDICAL / Infectious Diseases, Medical / Nursing, Clinical & internal medicine, Pharmacy / dispensing, Clinical and internal medicine